Moffitt logo

Clinical Trials Search

Clinical Trial 21148

Cancer Type: Multiple
Study Type: Supportive Care
NCT#:

Phase: N/A
Prinicipal Investigator: Laura Oswald

Call 813-745-6100
or 1-800-679-0775 Learn More
Overview

Study Title

Cancer Symptom Management Among Spanish-Speaking Patients

Summary

The goal of this study is to develop the first Spanish-language app for Hispanic cancer patients that targets patient activation to improve cancer symptom self-management.

Objective

Aim 1. Characterize Spanish-speaking Hispanic cancer survivors lived experiences with cancer symptoms, symptom management, patient activation, patient-provider communication, and preferences for cancer symptom management smartphone apps via qualitative focus groups. Aim 2. Examine descriptive data related to patient activation, symptom burden, HRQOL, and other patient reported outcomes (PROs) among Spanish-speaking Hispanic cancer patients. These data will be used to characterize the sample in relation to published severity thresholds and provide preliminary data for a future NIH grant proposal.

Treatments

Therapies

Medications

Inclusion Criteria

Inclusion Criteria:

  • 18 years of age or older
  • Self-identified Hispanic
  • Diagnosed with non-metastatic breast, prostate or colorectal cancer
  • Completed systemic cancer treatment in the past 12 months
  • Feels comfortable talking about health issues in Spanish
  • Has access to technology with videoconferencing capabilities and stable internet connection that they may use to join a focus group
  • Feels comfortable using smartphone applications on their own to help manage health issues
  • Able to provide informed consent

  • Exclusion Criteria

    Exclusion Criteria:

  • Documented or observable psychiatric or neurological disorder that would interfere with study participation.

  • If you are interested in learning more about clinical trials, our clinical trial navigators can discuss your options and recommend opportunities that may be suitable for you. Call 813-745-6100 or 1-800-679-0775 (toll-free) or submit a clinical trials inquiry form.